KLF4 is a therapeutically tractable brake on fibroblast activation that promotes resolution of pulmonary fibrosis - Penke, L R; Speth, J M; Huang, S K; Fortier, S M; Baas, J; Peters-Golden, M (JCI Insight, 2022)